Aurinia Pharma jumps on potential bid from Bristol Myers

Zhanna Hapanovich/iStock via Getty Images

  • Aurinia Pharma (NASDAQ:AUPH) shares quickly jumped to a session high, triggering a volatility halt after Bloomberg reported a potential bid from Bristol Myers Squibb (NYSE:BMY) to acquire the biopharma company.
  • According…

Click here to view the original article.